​NORA, Industrifonden and Unconventional Ventures invite a curated group of philantropists, angels and VC-funds, alongside key leaders from academia and the innovation ecosystem, to a closed-door discussion on how to unlock more risk capital into women’s health across the Nordics.

​We know there are both upstream and downstream barriers preventing capital allocation from reflecting the true disease burden and market opportunity in women’s health.

​At the same time, momentum is building across the Nordic region, with increasing public investment, a growing number of innovation hubs focused on the sector, and a unique foundation of Nordic health data that could enable major scientific breakthroughs if matched with the right resources and long-term commitment.

​The challenge ahead is how to structure collaboration across public, private, and philanthropic capital to unlock greater innovation and scale in women’s health. As well as knowledge-sharing, peer learning, and collaboration across the investor community.

​This conversation brings together key players from the ecosystem for an honest discussion about whether there is a case for deeper Nordic collaboration in this space.

​Agenda

​1. Welcome & Opening

2. Interactive panel discussion: Unlocking more capital for women’s health in the Nordics
The panel includes Ekaterina Gianelli (Calm/Storm), Nina Rawal (World Economic Forum’s Women’s Health Investment Consortium), Jonas Jendi (Industrifonden), Minna Arve (Business Turku - Women's Health Hub & Eir), and Cristina Liungberg (CaseForHer & Maverick Collective). Unicef FemTech Ventures and Maternity Foundation will share inspirational cases.

​3. Market deep-dives: Menopause & Endometriosis
Two focused sessions showcasing exciting research, innovation and emerging solutions in menopause and endometriosis, exploring what is needed to de-risk the area, strengthen the investment case and unlock more later-stage capital.
Participants include researchers from Karolinska Institutet and University of Copenhagen, BioInnovation Institute, innovators from Gesynta Pharma, EndoGyn, and Impact Invest among others.

​4. Building a Nordic Investment Collaborative
Through an interactive session we'll explore the case for a Nordic Investment Collaborative bringing together early- and later-stage capital partners to foster continuous dialogue, shared learning, strengthened deal flow and coordinated action.

​5. Mingle & Networking

​About NORA
NORA is a non-profit organisation mobilising catalytic capital and cross-sector collaboration to close the women’s health gap. They’re launching a funding initiative for overlooked women’s health research in 2026.

​About Industrifonden
Industrifonden is an evergreen Nordic venture capital investor backing early-stage companies within deep tech and life sciences, with a focus on creating long-term impact.

​About Unconventional Ventures
Unconventional Ventures is a European VC firm backing pre-seed and seed-stage impact-focused companies led by underrepresented founders, who are solving the most pressing challenges of today across climate, health, education, and critical infrastructure.